ANI Pharmaceuticals | ANIP - Stammkapital

Aktienkurs
74.67
Täglich Wechseln
-0.15 -0.20%
Monatlich
-0.57%
Jährlich
16.20%
Q1 Prognose
72.43




Stammkapital Veränderung Datum
AbbVie USD 1.77B 1.75B 2025-06
ANI Pharmaceuticals USD 22.49M 760K 2025-12
Assertio Holdings USD 9K 0 2023-12
Aurora Cannabis CAD 56.71M 134.13K 2025-12
Canopy Growth CAD 368.28M 35.9M 2025-12
Eli Lilly USD 946.83M 354.23M 2025-06
Emergent BioSolutions USD 100K 0 2023-06
Heron Therapeutics USD 188.31M 4.99M 2025-12
Hikma Pharmaceutical USD 221.89M 181.89M 2025-12
Knight Therapeutics CAD 99.68M 24.66K 2025-09
Nektar Therapeutics USD 19K 0 2024-09
Novartis USD 1.91B 10.64M 2025-12
Omeros USD 611K 17K 2023-12
Perrigo USD 137.6M 0 2025-12
Sun Pharmaceuticals INR 2.4B 35K 2025-09
Teva Pharmaceutical Industries USD 1.15B 0 2025-12